Affymetrix Inc Watch

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1 (F) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Hereby Agree to the Joint Filing With All Other Reporting Entities (As Such Term Is Defined in the Schedule 13g) on Behalf of Each of Them of a Statement on Schedule 13g/a (Including Amendments Thereto) With Respect to the Common Stock, $0.01 Par Value Per Share, of Affymetrix,inc., and That This Agreement Is Included as an Exhibit to Such Joint Filing. This Agreement May Be Executed in Any Number of Counterparts All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Hereby Execute This Agreement This 26th Day of January, 2016. Levin Capital Strategies, L.P. By:/S/ John A. Levin John A. Levin Chairman and C.E.O. Lcs, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs Event Partners, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs L/S, LLC By:/S/ John A. Levin John A. Levin General Partner By:/S/ John A. Levin John A. Levin

from SC 13G 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1 (F) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Hereby Agree to the Joint Filing With All Other Reporting Entities (As Such Term Is Defined in the Schedule 13g) on Behalf of Each of Them of a Statement on Schedule 13g/a (Including Amendments Thereto) With Respect to the Common Stock, $0.01 Par Value Per Share, of Affymetrix,inc., and That This Agreement Is Included as an Exhibit to Such Joint Filing. This Agreement May Be Executed in Any Number of Counterparts All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Hereby Execute This Agreement This 12th Day of October, 2015. Levin Capital Strategies, L.P. By:/S/ John A. Levin John A. Levin Chairman and C.E.O. Lcs, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs Event Partners, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs L/S, LLC By:/S/ John A. Levin John A. Levin General Partner By:/S/ John A. Levin John A. Levin

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1 (F) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Hereby Agree to the Joint Filing With All Other Reporting Entities (As Such Term Is Defined in the Schedule 13g) on Behalf of Each of Them of a Statement on Schedule 13g/a (Including Amendments Thereto) With Respect to the Common Stock, $0.01 Par Value Per Share, of Affymetrix,inc., and That This Agreement Is Included as an Exhibit to Such Joint Filing. This Agreement May Be Executed in Any Number of Counterparts All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Hereby Execute This Agreement This 10th Day of January, 2015. Levin Capital Strategies, L.P. By:/S/ John A. Levin John A. Levin Chairman and C.E.O. Lcs, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs Event Partners, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs L/S, LLC By:/S/ John A. Levin John A. Levin General Partner By:/S/ John A. Levin John A. Levin

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1 (F) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Hereby Agree to the Joint Filing With All Other Reporting Entities (As Such Term Is Defined in the Schedule 13g) on Behalf of Each of Them of a Statement on Schedule 13g/a (Including Amendments Thereto) With Respect to the Common Stock, $0.01 Par Value Per Share, of Affymetrix,inc., and That This Agreement Is Included as an Exhibit to Such Joint Filing. This Agreement May Be Executed in Any Number of Counterparts All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Hereby Execute This Agreement This 30th Day of January, 2015. Levin Capital Strategies, L.P. By:/S/ John A. Levin John A. Levin Chairman and C.E.O. Lcs, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs Event Partners, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs L/S, LLC By:/S/ John A. Levin John A. Levin General Partner By:/S/ John A. Levin John A. Levin

from 8-K 32 pages Affymetrix, Inc. Shares of Common Stock (Par Value $0.01 Per Share) Controlled Equity Offeringsm Sales Agreement

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1 (F) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Hereby Agree to the Joint Filing With All Other Reporting Entities (As Such Term Is Defined in the Schedule 13g) on Behalf of Each of Them of a Statement on Schedule 13g/a (Including Amendments Thereto) With Respect to the Common Stock, $0.01 Par Value Per Share, of Affymetrix,inc., and That This Agreement Is Included as an Exhibit to Such Joint Filing. This Agreement May Be Executed in Any Number of Counterparts All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Hereby Execute This Agreement This 31st Day of January, 2014. Levin Capital Strategies, L.P. By:/S/ John A. Levin John A. Levin Chairman and C.E.O. Lcs, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs Event Partners, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs L/S, LLC By:/S/ John A. Levin John A. Levin General Partner By:/S/ John A. Levin John A. Levin

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1 (F) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Hereby Agree to the Joint Filing With All Other Reporting Entities (As Such Term Is Defined in the Schedule 13g) on Behalf of Each of Them of a Statement on Schedule 13g (Including Amendments Thereto) With Respect to the Common Stock, $0.01 Par Value Per Share, of Affymetrix,inc., and That This Agreement Be Included as an Exhibit to Such Joint Filing. This Agreement May Be Executed in Any Number of Counterparts All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Hereby Execute This Agreement This 10th Day of January, 2013. Levin Capital Strategies, L.P. By:/S/ John A. Levin John A. Levin Chairman and C.E.O. Lcs, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs Event Partners, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs L/S, LLC By:/S/ John A. Levin John A. Levin General Partner By:/S/ John A. Levin John A. Levin

from SC 13G 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1 (F) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Hereby Agree to the Joint Filing With All Other Reporting Entities (As Such Term Is Defined in the Schedule 13g) on Behalf of Each of Them of a Statement on Schedule 13g (Including Amendments Thereto) With Respect to the Common Stock, $0.01 Par Value Per Share, of Affymetrix, Inc., and That This Agreement Be Included as an Exhibit to Such Joint Filing. This Agreement May Be Executed in Any Number of Counterparts All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Hereby Execute This Agreement This 29th Day of October, 2012. Levin Capital Strategies, L.P. By:/S/ John A. Levin John A. Levin Chairman and C.E.O. Lcs, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs Event Partners, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs L/S, LLC By:/S/ John A. Levin John A. Levin General Partner By:/S/ John A. Levin John A. Levin

from S-3ASR 22 pages J.P. Morgan Securities Inc. Affymetrix, Inc. $250,000,000 [ ]% Senior Convertible Notes Due 2038 Form of Underwriting Agreement

from SC 13G/A 1 page Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g/A, Dated February 14, 2003, (The "Schedule 13g/A"), With Respect to the Common Stock, Par Value $.01 Per Share, of Affymetrix, Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g/A. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g/A, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the February 14, 2003. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President of Managing Member, Orbimed Advisors Inc. Orbimed Capital LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member By: /S/ Samuel D. Isaly Name: Samuel D. Isaly

from SC 13D 1 page <page> Exhibit 1 to Schedule 13d Joint Filing Agreement Each of the Undersigned Hereby Agrees and Consents That the Schedule 13d Filed Herewith (This "Schedule 13d") by Glaxo Wellcome PLC ("Glaxo Wellcome") Is Filed on Behalf of Each of Them Pursuant to the Authorization of Each of Them to Glaxo Wellcome to Make Such Filing and That Such Schedule 13d Is Filed Jointly on Behalf of Each of Them, Pursuant to Sections 13(d) and 13(g) of the U.S. Securities Exchange Act of 1934, as Amended, and the Rules Promulgated Thereunder. Each of These Persons Is Not Responsible for the Completeness or Accuracy of the Information Concerning the Other Persons Making This Filing Unless Such Person Knows or Has Reason to Believe That Such Information Is Inaccurate. This Agreement May Be Signed in Counterparts. Glaxo Wellcome PLC Glaxo Group Limited By: /S/ S. J. Cowden By: /S/ S. J. Cowden Title: Secretary Title: Secretary Glaxo Venture Limited Glaxo Wellcome Americas Inc. By: /S/ S. J. Cowden By: /S/ S. J. Cowden Title: Director Title: Director Affymax N.V. Affymax Technologies N.V. By: /S/ Victoria Llewellyn By: /S/ Victoria Llewellyn Title: Company Secretary Title: Company Secretary Page 26 of 102 <page> Mr. Douglas M. Hurt Dr. Barry C. Ross By: /S/ Douglas M. Hurt By: /S/ Dr. Barry C. Ross Dated: February 16, 1999 Page 27 of 102

from 8-A12G ~50 pages Underwriting agreement

from S-1/A ~50 pages Underwriting agreement